加速康复外科改变剖宫产术后流程指标并减少阿片类药物使用:一项质量改进项目
在大型整合医疗系统中对择期剖宫产患者实施加速康复外科(ERAS)项目,采用前后对比设计比较实施前12个月与实施后12个月的变化。实施后住院阿片类药物暴露(平均每日吗啡当量)从10.7降至5.4,多模式镇痛使用从9.7%升至88.8%,出院阿片类药物处方比例从85.9%降至82.2%,首次下床和首次固体进食时间缩短,住院时长、手术部位感染、再入院及母乳喂养率无显著变化。
要点
- ERAS实施后住院阿片暴露均值从10.7降至5.4吗啡当量。
- 多模式镇痛达标调整RR为9.13(95%CI 8.35-10.0)。
- 住院时长、手术部位感染、再入院及母乳喂养率无显著变化。
核心结论
- 在择期剖宫产患者中实施ERAS项目与阿片类药物住院及出院暴露减少相关,并改变了手术流程指标,且未使手术结局恶化。
研究设计与样本
- 前后对比研究,在大型整合医疗系统中比较ERAS项目实施前12个月与实施后12个月的流程和结局指标。
- 实施前12个月纳入4,689例择期剖宫产患者(试点机构:2015年3月1日至2016年2月29日,其他机构:2015年10月1日至2016年9月30日)。
- 实施后12个月纳入4,624例患者(试点机构:2016年4月1日至2017年3月31日,其他机构:2016年11月1日至2017年10月31日)。
主要发现
- 控制年龄、种族-民族、孕前体重指数、患者报告疼痛评分和医疗中心后,住院阿片暴露平均每日吗啡当量从10.7(95%CI 10.2-11.3)降至5.4(95%CI 4.8-5.9)。
- 多模式镇痛(即对乙酰氨基酚和椎管内麻醉)使用率从9.7%升至88.8%,达到多模式镇痛目标的调整RR为9.13(比较ERAS后与ERAS前;95%CI 8.35-10.0)。
- 患者报告可接受疼痛评分的时间比例从82.1%升至86.4%(P<.001)。
- 出院时门诊阿片类药物发放比例从85.9%降至82.2%(P<.001),平均发放药片数从38片降至26片(P<.001)。
- 术后首次下床活动时间减少2.7小时(95%CI -3.1至-2.4),术后首次固体进食时间减少11.1小时(95%CI -11.5至-10.7)。
关键数值与推荐
- 多模式镇痛定义为对乙酰氨基酚和椎管内麻醉。
- 达到多模式镇痛目标的调整RR为9.13(95%CI 8.35-10.0)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate implementation of an enhanced recovery after surgery (ERAS) program for patients undergoing elective cesarean delivery by comparing opioid exposure, multimodal analgesia use, and other process and outcome measures before and after implementation. METHODS: An ERAS program was implemented among patients undergoing elective cesarean delivery in a large integrated health care delivery system. We conducted a pre-post study of ERAS implementation to compare changes in process and outcome measures during the 12 months before and 12 months after implementation. RESULTS: The study included 4,689 patients who underwent an elective cesarean delivery in the 12 months before (pilot sites: March 1, 2015-February 29, 2016, all other sites: October 1, 2015-September 30, 2016), and 4,624 patients in the 12 months after (pilot sites: April 1, 2016-March 31, 2017, all other sites: November 1, 2016-October 31, 2017) ERAS program implementation. After ERAS implementation mean inpatient opioid exposure (average daily morphine equivalents) decreased from 10.7 equivalents (95% CI 10.2-11.3) to 5.4 equivalents (95% CI 4.8-5.9) controlling for age, race-ethnicity, prepregnancy body mass index, patient reported pain score, and medical center. The use of multimodal analgesia (ie, acetaminophen and neuraxial anesthesia) increased from 9.7% to 88.8%, the adjusted risk ratio (RR) for meeting multimodal analgesic goals was 9.13 (RR comparing post-ERAS with pre-ERAS; 95% CI 8.35-10.0) and the proportion of time patients reported acceptable pain scores increased from 82.1% to 86.4% (P<.001). Outpatient opioids dispensed at hospital discharge decreased from 85.9% to 82.2% post-ERAS (P<.001) and the average number of dispensed pills decreased from 38 to 26 (P<.001). The hours to first postsurgical ambulation decreased by 2.7 hours (95% CI -3.1 to -2.4) and the hours to first postsurgical solid intake decreased by 11.1 hours (95% CI -11.5 to -10.7). There were no significant changes in hospital length of stay, surgical site infections, hospital readmissions, or breastfeeding rates. CONCLUSIONS: Implementation of an ERAS program in patients undergoing elective cesarean delivery was associated with a reduction in opioid inpatient and outpatient exposure and with changes in surgical process measures of care without worsened surgical outcomes.
引用
- Hedderson M, Lee D, Hunt E, et al. Enhanced Recovery After Surgery to Change Process Measures and Reduce Opioid Use After Cesarean Delivery: A Quality Improvement Initiative. Obstet Gynecol. 2019. PMID: 31403591. doi:10.1097/AOG.0000000000003406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。